L. Terry Spencer

Repeated Adeno-Associated Virus Serotype 2 Aerosol-Mediated Cystic Fibrosis Transmembrane Regulator Gene Transfer to the Lungs of Patients With Cystic Fibrosis

Richard B. Moss, David M. Rodman, L. Terry Spencer et al. · CHEST Journal · 2004 · 383 citations

Pathogenesis, Pathology, Respiratory Infection +4

Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy

Mark Brantly, Jeffrey D. Chulay, Lili Wang et al. · Proceedings of the National Academy of Sciences · 2009 · 311 citations · Full text

Cell Therapy, In Vivo Gene Therapy, Transgene Expression +20

Repeated Aerosolized AAV-CFTR for Treatment of Cystic Fibrosis: A Randomized Placebo-Controlled Phase 2B Trial

Richard B. Moss, Carlos Milla, John L. Colombo et al. · Human Gene Therapy · 2007 · 267 citations

Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Serotype 2 <i>α</i> 1-Antitrypsin (AAT) Vector in AAT-Deficient Adults

Mark Brantly, L. Terry Spencer, Margaret Humphries et al. · Human Gene Therapy · 2006 · 174 citations

Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Alpha 1-Antitrypsin (rAAV2-CB-hAAT) Gene Vector to AAT-Deficient Adults

Terence R. Flotte, Mark Brantly, L. Terry Spencer et al. · Human Gene Therapy · 2004 · 145 citations

Molecular Virology, Human Alpha1-antitrypsin, Immunology +12